Homeostasis, injury and recovery dynamics at multiple scales in a self-organizing mouse intestinal crypt

  1. Louis Gall
  2. Carrie Duckworth
  3. Ferran Jardi
  4. Lieve Lammens
  5. Aimee Parker
  6. Ambra Bianco
  7. Holly Kimko
  8. David Mark Pritchard
  9. Carmen Pin  Is a corresponding author
  1. AstraZeneca, United Kingdom
  2. University of Liverpool, United Kingdom
  3. Janssen, Belgium
  4. Quadram Institute, United Kingdom

Abstract

The maintenance of the functional integrity of the intestinal epithelium requires a tight coordination between cell production, migration and shedding along the crypt-villus axis. Dysregulation of these processes may result in loss of the intestinal barrier and disease. With the aim of generating a more complete and integrated understanding of how the epithelium maintains homeostasis and recovers after injury, we have built a multi-scale agent-based model (ABM) of the mouse intestinal epithelium. We demonstrate that stable, self-organizing behaviour in the crypt emerges from the dynamic interaction of multiple signalling pathways, such as Wnt, Notch, BMP, ZNRF3/RNF43 and YAP-Hippo pathways, which regulate proliferation and differentiation, respond to environmental mechanical cues, form feedback mechanisms and modulate the dynamics of the cell cycle protein network. The model recapitulates the crypt phenotype reported after persistent stem cell ablation and after the inhibition of the CDK1 cycle protein. Moreover, we simulated 5-fluorouracil (5-FU)-induced toxicity at multiple scales starting from DNA and RNA damage, which disrupts the cell cycle, cell signalling, proliferation, differentiation and migration and leads to loss of barrier integrity. During recovery, our in-silico crypt regenerates its structure in a self-organizing, dynamic fashion driven by dedifferentiation and enhanced by negative feedback loops. Thus, the model enables the simulation of xenobiotic-, in particular chemotherapy-, induced mechanisms of intestinal toxicity and epithelial recovery. Overall, we present a systems model able to simulate the disruption of molecular events and its impact across multiple levels of epithelial organization and demonstrate its application to epithelial research and drug development.

Data availability

The current manuscript is a computational study. No data have been generated for this manuscript. Modelling code is uploaded as Source Code.zip file

Article and author information

Author details

  1. Louis Gall

    Clinical and Quantitative Pharmacology, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    Louis Gall, Employee and shareholder of AstraZeneca Plc.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1805-2357
  2. Carrie Duckworth

    Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    No competing interests declared.
  3. Ferran Jardi

    Preclinical Sciences and Translational Safety, Janssen, Beerse, Belgium
    Competing interests
    Ferran Jardi, Employee of Johnson & Johnson..
  4. Lieve Lammens

    Preclinical Sciences and Translational Safety, Janssen, Beerse, Belgium
    Competing interests
    Lieve Lammens, Employee and shareholder of Johnson & Johnson..
  5. Aimee Parker

    Gut Microbes and Health Programme, Quadram Institute, Norwich, United Kingdom
    Competing interests
    No competing interests declared.
  6. Ambra Bianco

    Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    Ambra Bianco, Employee and shareholder of AstraZeneca Plc.
  7. Holly Kimko

    Clinical and Quantitative Pharmacology, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    Holly Kimko, Employee and shareholder of AstraZeneca Plc.
  8. David Mark Pritchard

    Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7971-3561
  9. Carmen Pin

    Clinical and Quantitative Pharmacology, AstraZeneca, Cambridge, United Kingdom
    For correspondence
    carmen.pin@astrazeneca.com
    Competing interests
    Carmen Pin, Employee and shareholder of AstraZeneca Plc.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8734-6167

Funding

European Federation of Pharmaceutical Industries and Associations (Innovative Medicines Initiative 2,No. 116030)

  • Louis Gall
  • Carrie Duckworth
  • Ferran Jardi
  • Lieve Lammens
  • David Mark Pritchard
  • Carmen Pin

Horizon 2020 Framework Programme (Innovative Medicines Initiative 2,No. 116030)

  • Louis Gall
  • Carrie Duckworth
  • Ferran Jardi
  • Lieve Lammens
  • David Mark Pritchard
  • Carmen Pin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were performed in an Association for Assessment and Accreditation of Laboratory Animal Care approved rodent facility and in accordance with the applicable animal welfare guidelines and legislation. Experimental procedures were approved by the institutional ethics committee. Ten-week-old male C57/BL6Y mice were obtained from Charles River (France). Mice were housed in polysulfon cages with corncob bedding under standard conditions of room temperature (21{degree sign}C {plus minus} 2), relative humidity (55% {plus minus} 15) and a 12-h light cycle. Water and a certified rodent pelleted maintenance diet were supplied ad libitum. Nest material and rodent retreats were provided for environmental enrichment.

Copyright

© 2023, Gall et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,138
    views
  • 187
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Louis Gall
  2. Carrie Duckworth
  3. Ferran Jardi
  4. Lieve Lammens
  5. Aimee Parker
  6. Ambra Bianco
  7. Holly Kimko
  8. David Mark Pritchard
  9. Carmen Pin
(2023)
Homeostasis, injury and recovery dynamics at multiple scales in a self-organizing mouse intestinal crypt
eLife 12:e85478.
https://doi.org/10.7554/eLife.85478

Share this article

https://doi.org/10.7554/eLife.85478

Further reading

    1. Computational and Systems Biology
    2. Neuroscience
    Anna Cattani, Don B Arnold ... Nancy Kopell
    Research Article

    The basolateral amygdala (BLA) is a key site where fear learning takes place through synaptic plasticity. Rodent research shows prominent low theta (~3–6 Hz), high theta (~6–12 Hz), and gamma (>30 Hz) rhythms in the BLA local field potential recordings. However, it is not understood what role these rhythms play in supporting the plasticity. Here, we create a biophysically detailed model of the BLA circuit to show that several classes of interneurons (PV, SOM, and VIP) in the BLA can be critically involved in producing the rhythms; these rhythms promote the formation of a dedicated fear circuit shaped through spike-timing-dependent plasticity. Each class of interneurons is necessary for the plasticity. We find that the low theta rhythm is a biomarker of successful fear conditioning. The model makes use of interneurons commonly found in the cortex and, hence, may apply to a wide variety of associative learning situations.

    1. Cancer Biology
    2. Computational and Systems Biology
    Rosalyn W Sayaman, Masaru Miyano ... Mark LaBarge
    Research Article

    Effects from aging in single cells are heterogenous, whereas at the organ- and tissue-levels aging phenotypes tend to appear as stereotypical changes. The mammary epithelium is a bilayer of two major phenotypically and functionally distinct cell lineages: luminal epithelial and myoepithelial cells. Mammary luminal epithelia exhibit substantial stereotypical changes with age that merit attention because these cells are the putative cells-of-origin for breast cancers. We hypothesize that effects from aging that impinge upon maintenance of lineage fidelity increase susceptibility to cancer initiation. We generated and analyzed transcriptomes from primary luminal epithelial and myoepithelial cells from younger <30 (y)ears old and older >55y women. In addition to age-dependent directional changes in gene expression, we observed increased transcriptional variance with age that contributed to genome-wide loss of lineage fidelity. Age-dependent variant responses were common to both lineages, whereas directional changes were almost exclusively detected in luminal epithelia and involved altered regulation of chromatin and genome organizers such as SATB1. Epithelial expression of gap junction protein GJB6 increased with age, and modulation of GJB6 expression in heterochronous co-cultures revealed that it provided a communication conduit from myoepithelial cells that drove directional change in luminal cells. Age-dependent luminal transcriptomes comprised a prominent signal that could be detected in bulk tissue during aging and transition into cancers. A machine learning classifier based on luminal-specific aging distinguished normal from cancer tissue and was highly predictive of breast cancer subtype. We speculate that luminal epithelia are the ultimate site of integration of the variant responses to aging in their surrounding tissue, and that their emergent phenotype both endows cells with the ability to become cancer-cells-of-origin and represents a biosensor that presages cancer susceptibility.